GSK | GSK plc Stock Overview

(Stock Exchange: NYSE)

Day's Range	33.43 - 34.12
52 Week Range	32.83 - 45.93
Beta	0.62
Implied Volatility	27.41%
IV Rank	79.00%
Day's Volume	3,184,312
Average Volume	5,771,253
Shares Outstanding	2,040,265,000
Market Cap	69,287,399,400
Sector	Healthcare
Industry	Drug Manufacturers - General
IPO Date	1980-03-28

Valuation
Profitability
Growth
Health
P/E Ratio	22.34
Forward P/E Ratio	12.26
EPS	1.52
1YR Price Target	51.00
Dividend Yield	4.65%
Dividend Per Share	1.58
Dividend ExDate	2022-08-18
Dividend PayDate	2022-10-06
Employees	70,212
Country	UK
Website	GSK

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines.

GSK's peers: AMRN, AZN, BIIB, GRFS, NVS, RHHBY, BMY, AMGN, MRK, ABBV, GILD, JNJ, SNY, SCLX

*Chart delayed

Analyzing fundamentals for GSK we got that it has weak fundamentals where Valuation is considered to be slightly undervalued, Profitability is very poor, Growth is very bad and Health is weak. For more detailed analysis please see GSK Fundamentals page.

Watching at GSK technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on GSK Technicals page.